GL1X · GenesisL1 explorer

Research workbench

Structure of SARS-cov-2 spike receptor-binding domain complexed with its receptor equine ACE2

Analyse Structure of SARS-cov-2 spike receptor-binding domain complexed with its… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7W6U
Type
protein
Length
785 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Angiotensin-converting enzyme; Spike protein S1
EC
3.4.-.-
UniProt
F6V9L3, P0DTC2
Ligands
NAG, ZN
Pockets
5 · best druggability 0.68

Structure

x-ray diffraction · 2 distinct chains · 52% helix, 10% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAngiotensin-converting enzyme (EC 3.4.-.-)protein59763% helix, 4% strandF6V9L3
BSpike protein S1protein18818% helix, 26% strandP0DTC2

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · chains B
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17440.680.7671empty
24810.660.7844empty
32800.580.7830empty
4990.370.7523empty
5880.370.7620empty

Interfaces

1 interface between chains.

  • A–B · 850 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide, 1 glycan (disulfide, N-glycosylation).

Compared structures

  • 7W6U · Structure of SARS-CoV-2 spike receptor-binding domain complexed with its receptor equine… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.